✦ LIBER ✦

[12] TELAPREVIR (VX-950) IS A POTENT INHIBITOR OF HCV NS3 PROTEASES DERIVED FROM GENOTYPE NON-1 HCV-INFECTED PATIENTS

✍ Scribed by C. Lin; B.L. Hanzelka; U. Muh; L. Kovari; D.J. Bartels; A.M. Tigges; J. Miller; B.G. Rao; A.D. Kwong

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

12 Wild-type HCV NS3 protease re-emerges

✍ T. Kieffer; C. Sarrazin; D. Bartels; B. Hanzelka; U. Müh; M. Welker; D. Wincheri 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB

954 BI 201335, A POTENT HCV NS3 PROTEASE

✍ G. Kukolj; Y. Benhamou; M.P. Manns; M. Bourlière; S. Pol; M. Schuchmann; M. Cart 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Potency, safety, and pharmacokinetics of

✍ Michael P. Manns; Marc Bourlière; Yves Benhamou; Stanislas Pol; Maurizio Bonacin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 767 KB

[592] NEOPTERIN AND ALT AS MARKERS OF IN

✍ H.C. Gelderblom; S. Zeuzem; C.T. Weegink; N. Forestier; L. McNair; S. Purdy; P.L 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 272 KB

Characterization of vaniprevir, a hepati

✍ Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Bened 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 367 KB

1208 EVALUATION OF NS3 AMINO ACID VARIAN

✍ Strizki, J.M.; Barnard, R.J.O.; Cheney, C.; McHale, C.; Graham, D.; Himmelberger 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB